Proton beam radiation therapy for vestibular schwannomas – tumor control and hearing preservation rates: a systematic review and meta-analysis.
05/09/2023
/
Publications
This meta-analysis included 8 primary studies with a total number of 587 patients with vestibular schwannomas treated with proton radiation. Overall rate of...
Proton therapy and oral mucositis in oral & oropharyngeal cancers: outcomes, dosimetric and NTCP benefit.
05/09/2023
/
Publications
This is a study by the Apollo group Chennai, India. 22 patients with oral cavity and oropharyngeal cancers treated with IMPT were reviewed. The average mean...
Proton beam therapy in multimodal treatment for locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinus.
05/09/2023
/
Publications
This study from Japan reported clinical outcomes of patients with locally advanced nasal cavity and paranasal sinus (NPSCC) treated with postoperative PBT or...
Proton beam therapy for hepatocellular carcinoma with bile duct invasion.
05/09/2023
/
Publications
This study from Japan reported clinical outcomes of 15 patients with hepatocellular carcinoma with bile duct invasion (BDIHCC) treated with PBT. The median...
Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: Results of a randomized clinical trial.
05/09/2023
/
Publications
/
Clinical Trial
Published by the Loma Linda group, this study reported the results of their randomized trial compared PBT with TACE for HCC. Patients were randomized to receive...
Efficacy and Safety in Proton Therapy and Photon Therapy for Patients With Esophageal Cancer: A Meta-Analysis.
05/09/2023
/
Publications
Published in JAMA Network, this meta-analysis showed that photon therapy was associated with poor OS...
Proton radiotherapy as a treatment strategy to increase survival in locally advanced pancreatic cancer in the body and tail: a retrospective study.
05/09/2023
/
Publications
This study from Japan reported clinical outcomes of 200 patients with locally advanced pancreatic cancer (LAPC) treated with PT to a total dose of 67.5 GyE in...
Normo- or Hypo-Fractionated Photon or Proton Radiotherapy in the Management of Locally Advanced Unresectable Pancreatic Cancer: A Systematic Review.
05/09/2023
/
Publications
This review included 31 primary studies including CFRT 15, SBRT 10 and PBT 6 for evaluation. The range of median total dose reported in the CFRT group was 50.4...
Treatment of primary or recurrent non-resectable pancreatic cancer with proton beam irradiation combined with gemcitabine-based chemotherapy.
05/09/2023
/
Publications
This study reported results of 25 patients with localized nonresectable pancreatic cancer (15 patients) or local recurrent disease (10 patients) treated with...
Managing motion in PT
20/11/2020
/
Webinar
/
Model-based approach
Motion Management
IBA invites you to attend a webinar presented by two experts in the field of Motion Magement in Proton Therapy, Dr. Korevaar from the University Medical Centre...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.